Can combined T-cell- and antibody-based immunotherapy outsmart tumor cells?
Abken
H
H
Dept of Internal Medicine I, University of Cologne, Germany. Hinrich.Abken@Medizin.uni-koeln.DE
Hombach
A
A
Reinhold
U
U
Ferrone
S
S
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D006801:Humans; D007167:Immunotherapy; D009369:Neoplasms / Q000628:therapy*; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*
D000911:Antibodies, Monoclonal